Heart rhythm showdown: ablation may beat defibrillator for some patients
NCT ID NCT06294028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to treat a fast, dangerous heart rhythm called ventricular tachycardia in people with coronary artery disease and relatively good heart function. One treatment uses a catheter to burn the tiny area causing the problem (radiofrequency ablation), and the other uses a small device implanted in the chest to shock the heart back to normal (defibrillator). The goal is to see which approach leads to fewer serious events like death or hospital visits over three years. About 268 adults with a history of heart attack and a preserved pumping ability will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rangueil Hospital
RECRUITINGToulouse, France, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher dose of adenosine sharpen heart scans?
- Can two advanced heart maps guide a more precise fix for dangerous arrhythmias?
- Could a short course of steroids calm a dangerous heart rhythm?
- Dental repair may boost heart and metabolic health
- Heart attack aftermath: new imaging method may spot hidden danger zones better than standard tests
- New stent design tested in thousands with complex heart blockages